Baumer

Baumer Debt/EBITDA

The Total Debt to EBITDA Ratio of Baumer (BALM4.SA) as of Nov 15, 2026 is 0.47. In the previous year, Total Debt to EBITDA Ratio was 0.91 — a change of -48.06% (lower).

Debt/EBITDA

0.47

YoY

-48.06%

Last updated:

Total Debt to EBITDA Ratio of Baumer is 2024 0.47 . Total Debt to EBITDA Ratio of Baumer was 2023 0.91 . It decreases by -48.06% lower compared to the previous year.

The Baumer Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2017
9.66 BRL
Jan 1, 2018
5.92 BRL
Jan 1, 2019
3.37 BRL
Jan 1, 2020
1.10 BRL
Jan 1, 2021
1.76 BRL
Jan 1, 2022
1.43 BRL
Jan 1, 2023
0.91 BRL
Jan 1, 2024
0.47 BRL
The Baumer Debt/EBITDA history
YEARDebt/EBITDAYoY
0.47-48.06%
0.91-36.62%
1.43-18.72%
1.76+60.91%
1.10-67.44%
3.37-43.11%
5.92-38.73%
9.66+155.11%
3.79+96.92%
1.92+54.78%
1.24—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

Total Debt to EBITDA Ratio of Baumer is 0.47 in 2024.

Total Debt to EBITDA Ratio of Baumer changed from 0.91 to 0.47, representing a -48.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Baumer since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Baumer with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Baumer

All Key Metrics — Baumer